3.連結財務諸表及び主な注記
(1)連結財政状態計算書
| | | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | | 当連結会計年度 (2025年3月31日) |
資産 | | | |
流動資産 | | | |
現金及び現金同等物 | 47,044 | | 39,592 |
営業債権 | 73,802 | | 70,530 |
棚卸資産 | 52,651 | | 51,694 |
その他の金融資産 | 4,775 | | 4,308 |
その他の流動資産 | 9,575 | | 6,665 |
流動資産合計 | 187,849 | | 172,790 |
非流動資産 | | | |
有形固定資産 | 49,708 | | 48,374 |
のれん | 208,719 | | 206,500 |
無形資産 | 91,388 | | 80,649 |
持分法で会計処理されている投資 | 2,188 | | 1,821 |
その他の金融資産 | 13,987 | | 13,932 |
繰延税金資産 | 7,058 | | 6,120 |
その他の非流動資産 | 3,426 | | 2,293 |
非流動資産合計 | 376,477 | | 359,691 |
資産合計 | 564,327 | | 532,482 |
| | | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | | 当連結会計年度 (2025年3月31日) |
負債及び資本 | | | |
負債 | | | |
流動負債 | | | |
営業債務及びその他の債務 | 69,881 | | 65,665 |
借入金 | 36,922 | | 34,278 |
未払法人所得税等 | 2,311 | | 4,207 |
引当金 | 6,587 | | 7,725 |
その他の金融負債 | 6,251 | | 5,812 |
その他の流動負債 | 25,445 | | 22,865 |
流動負債合計 | 147,400 | | 140,555 |
非流動負債 | | | |
営業債務及びその他の債務 | 847 | | 597 |
借入金 | 248,123 | | 220,982 |
退職給付に係る負債 | 5,709 | | 5,544 |
引当金 | 3,431 | | 4,575 |
その他の金融負債 | 9,200 | | 8,358 |
繰延税金負債 | 9,109 | | 9,291 |
その他の非流動負債 | 1,340 | | 1,405 |
非流動負債合計 | 277,763 | | 250,755 |
負債合計 | 425,163 | | 391,310 |
資本 | | | |
資本金 | 48,423 | | 48,623 |
資本剰余金 | 41,797 | | 42,039 |
利益剰余金 | △2,773 | | 2,991 |
自己株式 | △568 | | △568 |
その他の資本の構成要素 | 52,635 | | 48,553 |
親会社の所有者に帰属する持分合計 | 139,515 | | 141,639 |
非支配持分 | △351 | | △468 |
資本合計 | 139,163 | | 141,171 |
負債及び資本合計 | 564,327 | | 532,482 |
E3697665230PHCホールディングス株式会社PHC Holdings Corporation通期第3号参考様式 [IFRS](連結)IFRStrueCTECTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse652302023-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-03-31jpigp_cor:TreasurySharesIFRSMember652302023-03-31jpigp_cor:RetainedEarningsIFRSMember652302023-03-31jpigp_cor:CapitalSurplusIFRSMember652302023-03-31jpigp_cor:ShareCapitalIFRSMember652302025-05-13652302025-03-31652302024-04-012025-03-31652302024-03-31652302023-04-012024-03-31652302023-03-31652302025-03-31jpigp_cor:NonControllingInterestsIFRSMember652302025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302025-03-31jpigp_cor:TreasurySharesIFRSMember652302025-03-31jpigp_cor:RetainedEarningsIFRSMember652302025-03-31jpigp_cor:CapitalSurplusIFRSMember652302025-03-31jpigp_cor:ShareCapitalIFRSMember652302024-04-012025-03-31jpigp_cor:NonControllingInterestsIFRSMember652302024-04-012025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-04-012025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-04-012025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-04-012025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-04-012025-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-04-012025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-04-012025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-04-012025-03-31jpigp_cor:TreasurySharesIFRSMember652302024-04-012025-03-31jpigp_cor:RetainedEarningsIFRSMember652302024-04-012025-03-31jpigp_cor:CapitalSurplusIFRSMember652302024-04-012025-03-31jpigp_cor:ShareCapitalIFRSMember652302024-03-31jpigp_cor:NonControllingInterestsIFRSMember652302024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-03-31jpigp_cor:TreasurySharesIFRSMember652302024-03-31jpigp_cor:RetainedEarningsIFRSMember652302024-03-31jpigp_cor:CapitalSurplusIFRSMember652302024-03-31jpigp_cor:ShareCapitalIFRSMember652302023-04-012024-03-31jpigp_cor:NonControllingInterestsIFRSMember652302023-04-012024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-04-012024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-04-012024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-04-012024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302023-04-012024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-04-012024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-04-012024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-04-012024-03-31jpigp_cor:TreasurySharesIFRSMember652302023-04-012024-03-31jpigp_cor:RetainedEarningsIFRSMember652302023-04-012024-03-31jpigp_cor:CapitalSurplusIFRSMember652302023-04-012024-03-31jpigp_cor:ShareCapitalIFRSMember652302023-03-31jpigp_cor:NonControllingInterestsIFRSMember652302023-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember652302024-04-012025-03-31tse-acediffr-65230:DiabetesManagementReportableSegmentMember652302024-04-012025-03-31tse-acediffr-65230:HealthcareSolutionsReportableSegmentMember652302024-04-012025-03-31tse-acediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember652302023-04-012024-03-31jpcrp_cor:ReportableSegmentsMember652302023-04-012024-03-31tse-acediffr-65230:DiabetesManagementReportableSegmentMember652302023-04-012024-03-31tse-acediffr-65230:HealthcareSolutionsReportableSegmentMember652302023-04-012024-03-31tse-acediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302023-04-012024-03-31jpcrp_cor:ReconcilingItemsMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure